New tentative approval for Amneal Pharms drug lisdexamfetamine dimesylate

Lisdexamfetamine dimesylate is the generic ingredient in one branded drug marketed by Takeda Pharms Usa and is included in two NDAs. There are nineteen patents protecting this compound. Drug patent…

The post New tentative approval for Amneal Pharms drug lisdexamfetamine dimesylate appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.